Accelagen

Accelagen is a company located in San Diego, California, specializing in gene-to-protein services. With a team of seven employees, Accelagen has generated $2 million in revenue. Accelagen's core offering is a gene-to-protein platform that leverages cutting-edge technologies. This platform encompasses Baculovirus Expression Vector System (BEVS), E. coli expression, mammalian expression, Wave Bioreactors, Cell Factory, and AKTA chromatography systems. These technologies work in concert to deliver high-quality proteins and expedite the entire process, from gene to final protein product. The company's gene-to-protein platform sets it apart by providing a comprehensive solution that integrates multiple expression systems and advanced purification techniques. This integrated approach ensures superior protein quality and accelerates timelines, making Accelagen a valuable partner for researchers and businesses requiring reliable protein production. For more information about Accelagen and its services, visit their website at accelagen.com.